Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

OXFORD PHARMS

  • FDA Approval
  • Oct. 26, 2023, 11:45 UTC
  • 35
  • 0 comments

FDA approve HYDROCHLOROTHIAZIDE

Comment Full text

DAVA PHARMS INC

  • FDA Approval
  • Oct. 26, 2023, 11:45 UTC
  • 29
  • 0 comments

FDA approve HYDROCHLOROTHIAZIDE

Comment Full text

OXFORD PHARMS

  • FDA Approval
  • Oct. 26, 2023, 11:45 UTC
  • 28
  • 0 comments

FDA approve HYDROCHLOROTHIAZIDE

Comment Full text

APOTEX INC

  • FDA Approval
  • Oct. 26, 2023, 11:45 UTC
  • 29
  • 0 comments

FDA approve ALPRAZOLAM

Comment Full text

INTL MEDICATION

  • FDA Approval
  • Oct. 26, 2023, 11:45 UTC
  • 30
  • 0 comments

FDA approve PHYTONADIONE

Comment Full text

ANBISON LAB

  • FDA Approval
  • Oct. 26, 2023, 11:45 UTC
  • 32
  • 0 comments

FDA approve BUPROPION HYDROCHLORIDE

Comment Full text

MYLAN

  • FDA Approval
  • Oct. 26, 2023, 11:45 UTC
  • 34
  • 0 comments

FDA approve DIVALPROEX SODIUM

Comment Full text

LUPIN

  • FDA Approval
  • Oct. 25, 2023, 16:20 UTC
  • 36
  • 0 comments

FDA approve CALCIUM;MAGNESIUM;POTASSIUM;SODIUM OXYBATES

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • Oct. 25, 2023, 11:53 UTC
  • 34
  • 0 comments

FDA approve FLUCONAZOLE

Comment Full text

BRAINTREE LABS

  • FDA Approval
  • Oct. 25, 2023, 11:53 UTC
  • 42
  • 0 comments

FDA approve MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM SULFATE

Comment Full text
  • Previous
  • 643
  • 644
  • 645
  • 646
  • 647
  • Next

Search

News categories

  • Technical Exchange News(11967)
  • Event(5000)
  • SEC News(246768)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(148726)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin